The Sunshine state citrus industry is celebrating the FDA's proposed amendment, saying the changes would "better align with ...

Sanofi SA ( (SNY) ), Sanofi ( (DE:SNW) ), Sanofi ( (SNYNF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational CapabilitiesStrengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA ...

Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 millionAs of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, ...

BENGALURU: Karnataka Health Minister Dinesh Gundu Rao said on Monday that all medicines under the Department of Ayush, including those in Ayurvedic, Unani, Sidd ...

In a significant move addressing the rising concerns over unregulated gig economy activities, Chief Minister Pramod Sawant announced in the Goa Legislative Assembly on Monday that the state government ...

The Food and Drug Administration (FDA) is to list several substances similar to etomidate — an increasingly abused anesthetic ...

Basel: Roche has announced new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term ...

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration: Basel Monday, August 4, 2025, 11:00 Hrs [ ...

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in wet AMD, the leading cause of vision loss in people over ...

Swiss pharma giant Roche announced positive five-year efficacy, safety and durability data from the Phase III Portal study, a ...